Pluri Inc. (PLUR) DCF Valuation

Pluri Inc. (PLUR) DCF -Bewertung

IL | Healthcare | Biotechnology | NASDAQ
Pluri Inc. (PLUR) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Pluri Inc. (PLUR) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Entdecken Sie die finanziellen Aussichten von Pluri Inc. (PLUR) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Annahmen in Bezug auf Wachstum, Margen und Ausgaben ein, um den intrinsischen Wert von Pluri Inc. (PLUR) zu bestimmen und Ihren Investitionsansatz zu verfeinern.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue .0 .0 .2 .3 .3 .3 .2 .2 .2 .1
Revenue Growth, % 0 -100 0 22.65 13.59 -15.94 -15.94 -15.94 -15.94 -15.94
EBITDA -27.4 -48.4 -39.4 -27.7 -20.2 -.2 -.1 -.1 -.1 -.1
EBITDA, % -119069.57 100 -16852.14 -9645.3 -6203.99 -60 -60 -60 -60 -60
Depreciation 1.6 1.4 1.1 .4 .3 .3 .2 .2 .2 .1
Depreciation, % 6826.09 100 450 126.13 77.61 95.52 95.52 95.52 95.52 95.52
EBIT -29.0 -49.8 -40.5 -28.0 -20.5 -.2 -.1 -.1 -.1 -.1
EBIT, % -125895.65 100 -17302.14 -9771.43 -6281.6 -60 -60 -60 -60 -60
Total Cash 45.8 65.0 55.0 40.2 30.0 .3 .2 .2 .2 .1
Total Cash, percent .2 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.6 1.5 1.3 .5 .6
Account Receivables, % 7000 100 564.53 183.62 198.16
Inventories .6 .6 .0 .3 .0 .2 .1 .1 .1 .1
Inventories, % 2413.04 100 0 93.73 0 58.75 58.75 58.75 58.75 58.75
Accounts Payable 2.0 2.5 1.8 1.8 1.0 .3 .2 .2 .2 .1
Accounts Payable, % 8556.52 100 762.82 631.36 295.71 100 100 100 100 100
Capital Expenditure -.3 -.4 -.3 -.3 -.3 -.2 -.2 -.2 -.1 -.1
Capital Expenditure, % -1173.91 100 -119.66 -91.29 -99.08 -78.07 -78.07 -78.07 -78.07 -78.07
Tax Rate, % 2.14 2.14 2.14 2.14 2.14 2.14 2.14 2.14 2.14 2.14
EBITAT -29.2 -49.9 -40.1 -27.5 -20.0 -.2 -.1 -.1 -.1 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -28.0 -48.2 -39.3 -26.8 -20.8 -.6 -.1 -.1 -.1 .0
WACC, % 7.55 7.55 7.54 7.51 7.51 7.53 7.53 7.53 7.53 7.53
PV UFCF
SUM PV UFCF -.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -1
Present Terminal Value -1
Enterprise Value -1
Net Debt 23
Equity Value -24
Diluted Shares Outstanding, MM 5
Equity Value Per Share -4.60

What You Will Get

  • Real Pluri Inc. Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Pluri Inc. (PLUR).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Pluri Inc. (PLUR).
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Pluri Inc.'s (PLUR) fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Pluri Inc. (PLUR).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Pluri Inc. (PLUR).

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Pluri Inc. (PLUR).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with options for customizable inputs specific to Pluri Inc. (PLUR).
  • Adjustable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates relevant to Pluri Inc. (PLUR).
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Pluri Inc. (PLUR).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of Pluri Inc. (PLUR).

How It Works

  • Download: Obtain the pre-configured Excel file containing Pluri Inc.'s (PLUR) financial metrics.
  • Customize: Modify projections, such as revenue growth, EBITDA margin, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and analyze results immediately.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose Pluri Inc. (PLUR) Calculator?

  • All-in-One Solution: Features DCF, WACC, and financial ratio analyses seamlessly integrated.
  • Flexible Inputs: Modify highlighted fields to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Pluri Inc.'s intrinsic value and Net Present Value.
  • Ready-to-Use Data: Comes with historical and projected data for reliable calculations.
  • Expert-Level Tool: Perfect for financial analysts, investors, and business advisors.

Who Should Use Pluri Inc. (PLUR)?

  • Professional Investors: Create comprehensive and accurate valuation models for investment analysis.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions.
  • Consultants and Advisors: Deliver precise valuation insights for Pluri Inc. (PLUR) to clients.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Pluri Inc. (PLUR) are assessed in the market.

What the Template Contains

  • Pre-Filled DCF Model: Pluri Inc.’s (PLUR) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Pluri Inc.’s (PLUR) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.